SCHEMBL9141527

SCHEMBL9141527

Cc1ccc(NC(=O)c2ccccc2Br)c(S)c1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ F10 P00742 1/20 0.65
▸ RAB9A P51151 8/20 0.52
▸ SMN1; SMN2 Q16637 6/20 0.52
▸ NPC1 O15118 5/20 0.52
▸ HPGD P15428 1/20 0.52
▸ LMNA P02545 3/20 0.50
▸ PKM P14618 2/20 0.49
▸ TP53 P04637 1/20 0.49
▸ MAPT P10636 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ GAA P10253 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ NFKB2 Q00653 1/20 0.49
▸ RELA Q04206 1/20 0.49
▸ TSHR P16473 1/20 0.49
▸ HSD17B10 Q99714 1/20 0.49
▸ MEN1 O00255 1/20 0.49
▸ KMT2A Q03164 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28701891 0.87 F10 (0.66) F10RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL20022682 0.83 RAB9A (0.59) F10RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL9682543 0.79 KCNMA1 (0.65) RAB9ASMN1; SMN2NPC1HPGDPKM
SCHEMBL8060238 0.79 NPC1 (0.75) F10RAB9ASMN1; SMN2NPC1HPGD
SCHEMBL31092076 0.75 HPGD (0.68) RAB9ASMN1; SMN2NPC1HPGDLMNA
SCHEMBL29168826 0.75 RAB9A (0.73) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL30758595 0.75 RAB9A (0.73) RAB9ASMN1; SMN2NPC1ALDH1A1MEN1
SCHEMBL28695522 0.74 KMT2A (0.70) RAB9ASMN1; SMN2NPC1HPGDLMNA
SCHEMBL27732526 0.73 TDP1 (0.53) RAB9ASMN1; SMN2NPC1HPGDPKM
SCHEMBL5130336 0.72 RAB9A (0.54) RAB9ASMN1; SMN2NPC1TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5420292-A Biphenyl-tetrazole intermediate compounds ZENECA LIMITED (GB) 1995-05-30 — — US disclosed
US-5294716-A Chemical process for making angiotesin II antagonist compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-03-15 — — US disclosed
Send feedback